Hangzhou Tigermed Consulting Co., Ltd (SHE:300347)

China · Delayed Price · Currency is CNY

60.50

-0.77 (-1.26%)

Feb 26, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Clinical Trial Solutions	3.18B	4.17B	4.13B	2.99B	-
Clinical Trial Solutions Growth	-23.75%	1.04%	37.80%	-	-
Clinical-Related and Laboratory Services	3.30B	3.12B	2.88B	2.19B	-
Clinical-Related and Laboratory Services Growth	5.61%	8.51%	31.12%	-	-
Unallocated Other	129.04M	94.93M	83.93M	26.17M	-
Unallocated Other Growth	35.93%	13.10%	220.69%	-	-
Service Industry	-	-	-	-	3.19B
Service Industry Growth	-	-	-	-	13.88%
Total	6.60B	7.38B	7.09B	5.21B	3.19B
Total Growth	-10.58%	4.21%	35.91%	63.32%	13.88%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	3.55B	4.23B	3.60B	2.76B	1.91B
China Growth	-16.21%	17.57%	30.68%	44.55%	19.16%
Overseas	3.06B	3.15B	3.48B	2.46B	1.29B
Overseas Growth	-3.00%	-9.60%	41.77%	91.16%	6.85%
Total	6.60B	7.38B	7.09B	5.21B	3.19B
Total Growth	-10.58%	4.21%	35.91%	63.32%	13.88%

Source: S&P Global Market Intelligence.